| 0 |
POSTERIOR SEGMENT OF EYE ANOMALY |
1 |
0.1429 |
| 1 |
CORECTOPIA |
1 |
0.0769 |
| 2 |
BREAST CONSERVING SURGERY |
29 |
0.0566 |
| 3 |
CONJUNCTIVAL BLEB |
3 |
0.0556 |
| 4 |
ANTERIOR SEGMENT ISCHAEMIA |
1 |
0.0526 |
| 5 |
IRIS ATROPHY |
4 |
0.0193 |
| 6 |
CORNEAL DECOMPENSATION |
2 |
0.0124 |
| 7 |
PIGMENT DISPERSION SYNDROME |
1 |
0.0105 |
| 8 |
IRIS HYPOPIGMENTATION |
1 |
0.0093 |
| 9 |
OBSTRUCTION |
33 |
0.0083 |
| 10 |
ANTERIOR CHAMBER FIBRIN |
1 |
0.0078 |
| 11 |
VASCULAR STENT STENOSIS |
3 |
0.0071 |
| 12 |
EUSTACHIAN TUBE OBSTRUCTION |
1 |
0.0061 |
| 13 |
PRINZMETAL ANGINA |
6 |
0.0060 |
| 14 |
HYPHAEMA |
3 |
0.0057 |
| 15 |
FULL BLOOD COUNT ABNORMAL |
30 |
0.0028 |
| 16 |
TOXIC ANTERIOR SEGMENT SYNDROME |
3 |
0.0027 |
| 17 |
SINONASAL OBSTRUCTION |
1 |
0.0025 |
| 18 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
34 |
0.0020 |
| 19 |
ARTERIOSPASM CORONARY |
8 |
0.0020 |
| 20 |
IRIS ADHESIONS |
1 |
0.0019 |
| 21 |
EOSINOPHILIA |
33 |
0.0019 |
| 22 |
VITRECTOMY |
1 |
0.0017 |
| 23 |
SINUS DISORDER |
33 |
0.0017 |
| 24 |
CORNEAL OPACITY |
2 |
0.0015 |
| 25 |
CARDIAC ENZYMES INCREASED |
1 |
0.0014 |
| 26 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
3 |
0.0014 |
| 27 |
MENTAL IMPAIRMENT |
33 |
0.0014 |
| 28 |
CORNEAL DEPOSITS |
1 |
0.0013 |
| 29 |
RESPIRATORY DISORDER |
33 |
0.0011 |
| 30 |
CYSTOID MACULAR OEDEMA |
2 |
0.0011 |
| 31 |
FOREIGN BODY IN EYE |
1 |
0.0010 |
| 32 |
CORNEAL OEDEMA |
2 |
0.0009 |
| 33 |
HALO VISION |
1 |
0.0009 |
| 34 |
FRACTURED COCCYX |
1 |
0.0008 |
| 35 |
CONJUNCTIVAL HAEMORRHAGE |
3 |
0.0008 |
| 36 |
MENTAL DISORDER |
33 |
0.0008 |
| 37 |
PERIODONTAL DISEASE |
1 |
0.0007 |
| 38 |
PRODUCTIVE COUGH |
33 |
0.0007 |
| 39 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
31 |
0.0006 |
| 40 |
PRODUCT DEPOSIT |
1 |
0.0006 |
| 41 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
33 |
0.0006 |
| 42 |
CARDIAC FAILURE ACUTE |
4 |
0.0006 |
| 43 |
PUSTULAR PSORIASIS |
2 |
0.0006 |
| 44 |
PUPIL FIXED |
1 |
0.0006 |
| 45 |
WHEEZING |
33 |
0.0006 |
| 46 |
RHINORRHOEA |
34 |
0.0005 |
| 47 |
NASAL CONGESTION |
30 |
0.0005 |
| 48 |
SLEEP DISORDER |
34 |
0.0005 |
| 49 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
34 |
0.0005 |
| 50 |
MIDDLE EAR EFFUSION |
1 |
0.0005 |
| 51 |
ELECTROCARDIOGRAM T WAVE INVERSION |
1 |
0.0005 |
| 52 |
PRODUCT PACKAGE ASSOCIATED INJURY |
1 |
0.0004 |
| 53 |
DENTAL OPERATION |
1 |
0.0004 |
| 54 |
DIABETIC COMA |
1 |
0.0004 |
| 55 |
BREAST CANCER |
33 |
0.0004 |
| 56 |
SINUSITIS |
34 |
0.0003 |
| 57 |
CHEST DISCOMFORT |
33 |
0.0003 |
| 58 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 59 |
ASTHMA |
33 |
0.0003 |
| 60 |
SKIN WEEPING |
1 |
0.0003 |
| 61 |
SPINAL STENOSIS |
1 |
0.0002 |
| 62 |
ISCHAEMIA |
1 |
0.0002 |
| 63 |
TREMOR |
33 |
0.0002 |
| 64 |
BLOOD COUNT ABNORMAL |
3 |
0.0002 |
| 65 |
DRUG TOLERANCE |
1 |
0.0002 |
| 66 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 67 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
1 |
0.0002 |
| 68 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 69 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 70 |
SCAR |
3 |
0.0002 |
| 71 |
STRESS CARDIOMYOPATHY |
1 |
0.0002 |
| 72 |
HYPERTENSION |
33 |
0.0002 |
| 73 |
DEPRESSION |
35 |
0.0002 |
| 74 |
INFARCTION |
1 |
0.0001 |
| 75 |
ACUTE MYOCARDIAL INFARCTION |
4 |
0.0001 |
| 76 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 77 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 78 |
COUGH |
34 |
0.0001 |
| 79 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 80 |
ANXIETY |
33 |
0.0001 |
| 81 |
LACERATION |
1 |
0.0001 |
| 82 |
PNEUMONIA |
33 |
0.0001 |
| 83 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 84 |
PETECHIAE |
1 |
0.0001 |
| 85 |
CATARACT |
5 |
0.0001 |
| 86 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 87 |
MYDRIASIS |
1 |
0.0001 |
| 88 |
MALAISE |
33 |
0.0001 |
| 89 |
DEVICE BREAKAGE |
3 |
0.0001 |
| 90 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 91 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 92 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 93 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 94 |
DYSPNOEA |
34 |
0.0001 |
| 95 |
SYRINGE ISSUE |
1 |
0.0001 |
| 96 |
THIRST |
1 |
0.0001 |
| 97 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 98 |
FRACTURE |
1 |
0.0001 |
| 99 |
FOOT FRACTURE |
1 |
0.0001 |
| 100 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 101 |
SKIN FISSURES |
1 |
0.0001 |
| 102 |
SPINAL FRACTURE |
1 |
0.0000 |
| 103 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 104 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 105 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 106 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 107 |
PAIN OF SKIN |
1 |
0.0000 |
| 108 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 109 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 110 |
PRODUCT QUALITY ISSUE |
4 |
0.0000 |
| 111 |
PANIC ATTACK |
1 |
0.0000 |
| 112 |
CHEST PAIN |
5 |
0.0000 |
| 113 |
POLLAKIURIA |
1 |
0.0000 |
| 114 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 115 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 116 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 117 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 118 |
TINNITUS |
1 |
0.0000 |
| 119 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 120 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 121 |
HEART RATE INCREASED |
2 |
0.0000 |
| 122 |
ECZEMA |
1 |
0.0000 |
| 123 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 124 |
EYE PAIN |
1 |
0.0000 |
| 125 |
BONE PAIN |
1 |
0.0000 |
| 126 |
IRRITABILITY |
1 |
0.0000 |
| 127 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 128 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 129 |
VISION BLURRED |
2 |
0.0000 |
| 130 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 131 |
INJURY |
1 |
0.0000 |
| 132 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 133 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 134 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 135 |
CARDIAC ARREST |
1 |
0.0000 |
| 136 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 137 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 138 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 139 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 140 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 141 |
INFLUENZA |
1 |
0.0000 |
| 142 |
FEELING ABNORMAL |
2 |
0.0000 |
| 143 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 144 |
DRY SKIN |
1 |
0.0000 |
| 145 |
INFECTION |
1 |
0.0000 |
| 146 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 147 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 148 |
HOSPITALISATION |
1 |
0.0000 |
| 149 |
DRUG INTERACTION |
1 |
0.0000 |
| 150 |
URTICARIA |
1 |
0.0000 |
| 151 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 152 |
PYREXIA |
2 |
0.0000 |
| 153 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 154 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 155 |
PRURITUS |
2 |
0.0000 |
| 156 |
SOMNOLENCE |
1 |
0.0000 |
| 157 |
OFF LABEL USE |
4 |
0.0000 |
| 158 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 159 |
HEADACHE |
2 |
0.0000 |
| 160 |
DRUG INEFFECTIVE |
4 |
0.0000 |
| 161 |
FALL |
1 |
0.0000 |
| 162 |
ASTHENIA |
1 |
0.0000 |
| 163 |
FATIGUE |
2 |
0.0000 |
| 164 |
NAUSEA |
2 |
0.0000 |
| 165 |
ARTHRALGIA |
1 |
0.0000 |
| 166 |
RASH |
1 |
0.0000 |
| 167 |
DIZZINESS |
1 |
0.0000 |